1. Table of Contents 1.1 List of Tables 1.2 List of Figures 2. Executive Summary 2.1 Report Guide 2.2 Methodology 2.3 Market Segmentation 2.4 Point of Care (PoC) Molecular Diagnostics Market- Key Findings, 2020 3. Strategic Imperatives on Global Point of Care (PoC) Molecular Diagnostics Market 3.1 COVID-19 Impact Analysis 3.2 Market Trends- Across Types, Applications, End User Types, Countries 3.3 Insights into Main Market Categories 3.4 Market Drivers and Restraints 3.5 Growth Opportunities Critical for Future Success 3.6 Key Point of Care (PoC) Molecular Diagnostics Companies 4. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 Outlook by Application 4.1 Infectious Diseases 4.2 Oncology 4.3 Hematology 4.4 Prenatal Testing 4.5 Endocrinology 4.6 Others 5. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 Outlook by Technology 5.1 PCR Based 5.2 Genetic Sequencing Bassed 5.3 Hybridization Based 5.4 Microarray Based 6. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 Outlook by End User 6.1 Laboratories 6.2 Hospitals 6.3 Homecare 6.4 Others 7 Asia Pacific Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 7.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Asia Pacific market 7.2 Top Applications contributing to Asia Pacific Point of Care (PoC) Molecular Diagnostics 7.3 Top countries contributing to Asia Pacific Point of Care (PoC) Molecular Diagnostics 8 Europe Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 8.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Europe market 8.2 Top Applications contributing to Europe Point of Care (PoC) Molecular Diagnostics 8.3 Top countries contributing to Europe Point of Care (PoC) Molecular Diagnostics 9 North America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 9.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to North America market 9.2 Top Applications contributing to North America Point of Care (PoC) Molecular Diagnostics 9.3 Top countries contributing to North America Point of Care (PoC) Molecular Diagnostics 10 South and Central America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 10.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to South and Central America market 10.2 Top Applications contributing to South and Central America Point of Care (PoC) Molecular Diagnostics 10.3 Top countries contributing to South and Central America Point of Care (PoC) Molecular Diagnostics 11 Middle East Africa Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2026 11.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Middle East Africa market 11.2 Top Applications contributing to Middle East Africa Point of Care (PoC) Molecular Diagnostics 11.3 Top countries contributing to Middle East Africa Point of Care (PoC) Molecular Diagnostics 12 Business Profiles of Leading Companies 12.1 Business Description, SWOT and Financial Analysis of Companies in Point of Care (PoC) Molecular Diagnostics market 12.2 Abaxis  12.3 Abbott Laboratories 12.4 Alere Inc 12.5 Bayer Healthcare 12.6 BioMerieux 12.7 Bio-Rad Laboratories 12.8 Dako 12.9 Danaher Corporation 12.10 Nipro Diagnostics 12.11 Nova Biomedical 13 Recent Industry Developments 14 Appendix 14.1 OGAnalysis Expertise 14.2 Sources and Methodology 14.3 Contacts